Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B M Rifkind

Showing results (21-30 of 83) with videos related to

Pageof 9
Sort By:
JAMA|October 14, 1983
Lipid Research Clinics Program reference values for hyperlipidemia and hypolipidemiaB M Rifkind, P Segal
Israel Journal of Medical Sciences|November 1, 1982
Changing patterns of cardiovascular disease mortality in the United StatesM Feinleib, B M Rifkind
JAMA|November 28, 1986
Cholesterol lowering and the reduction of coronary heart disease riskB M Rifkind, C Lenfant
Annals of Epidemiology|March 10, 1998
Population trends in HDL-cholesterol levelsB M Rifkind, D J Gordon
Clinics in Laboratory Medicine|March 1, 1989
Lowering blood cholesterol to reduce coronary heart disease riskR H Bradford, B M Rifkind
American Journal of Diseases of Children (1960)|April 1, 1993
Cholesterol measurement in childrenP T Einhorn, B M Rifkind
Progress in Clinical and Biological Research|January 1, 1988
The Lipid Research Clinics Primary Prevention Trial and its aftermathJ G Brook, B M Rifkind
Annals of Internal Medicine|November 1, 1987
3-Hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors: a new class of cholesterol-lowering agentsD J Gordon, B M Rifkind
The American Journal of Cardiology|May 2, 1989
Treating high blood cholesterol in the older patientD J Gordon, B M Rifkind
The New England Journal of Medicine|November 9, 1989
High-density lipoprotein--the clinical implications of recent studiesD J Gordon, B M Rifkind
Pageof 9

Showing results (21-30 of 83) with videos related to

Sort By:
Pageof 9
JAMA|October 14, 1983
Lipid Research Clinics Program reference values for hyperlipidemia and hypolipidemiaB M Rifkind, P Segal
Israel Journal of Medical Sciences|November 1, 1982
Changing patterns of cardiovascular disease mortality in the United StatesM Feinleib, B M Rifkind
JAMA|November 28, 1986
Cholesterol lowering and the reduction of coronary heart disease riskB M Rifkind, C Lenfant
Annals of Epidemiology|March 10, 1998
Population trends in HDL-cholesterol levelsB M Rifkind, D J Gordon
Clinics in Laboratory Medicine|March 1, 1989
Lowering blood cholesterol to reduce coronary heart disease riskR H Bradford, B M Rifkind
American Journal of Diseases of Children (1960)|April 1, 1993
Cholesterol measurement in childrenP T Einhorn, B M Rifkind
Progress in Clinical and Biological Research|January 1, 1988
The Lipid Research Clinics Primary Prevention Trial and its aftermathJ G Brook, B M Rifkind
Annals of Internal Medicine|November 1, 1987
3-Hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors: a new class of cholesterol-lowering agentsD J Gordon, B M Rifkind
The American Journal of Cardiology|May 2, 1989
Treating high blood cholesterol in the older patientD J Gordon, B M Rifkind
The New England Journal of Medicine|November 9, 1989
High-density lipoprotein--the clinical implications of recent studiesD J Gordon, B M Rifkind
Pageof 9